Entrada Therapeutics
TRDA
$13.16
Share price
-2.95%
Change (1 day)
10.13%
Change (1 year)
Categories
Entrada Therapeutics (TRDA) - P/B ratio
P/B ratio as of May 2024 : 1.88
According to Entrada Therapeutics's latest financial reports the company has a price-to-book ratio of 1.88.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Entrada Therapeutics - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.08 | 4% |
| 2022-12-31 | 2.00 | 11.67% |
| 2021-12-31 | 1.79 | |
| 2020-12-31 | N/A |